Check sweat glands, hair follicles in mycosis fungoidesApril 22, 2015Lymphoma & Plasma Cell Disorders
ABVD and Stanford V similar for bulky mediastinal Hodgkin’s lymphomaApril 20, 2015Lymphoma & Plasma Cell Disorders
Chemotherapy and stem-cell transplantation combination appears safeApril 13, 2015Lymphoma & Plasma Cell Disorders
Lenalidomide now approved for newly diagnosed multiple myelomaFebruary 18, 2015Lymphoma & Plasma Cell Disorders
JAK inhibitor more effective than standard therapy for polycythemia veraJanuary 28, 2015Lymphoma & Plasma Cell Disorders
ASPIRE: Carfilzomib-Len-Dex ‘a new standard of care’ for relapsed multiple myelomaDecember 7, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
VIDEO: Biomarker may reveal lymphoma risk in Sjögren’s syndromeNovember 21, 2014Lymphoma & Plasma Cell Disorders
FDA panel votes against panobinostat as add-on therapy for multiple myelomaNovember 7, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Thumbs-up on laparoscopic splenectomy for malignanciesNovember 4, 2014Lymphoma & Plasma Cell Disorders
PET-CT better predicted follicular lymphoma survivalSeptember 24, 2014Lymphoma & Plasma Cell DisordersFollicular Lymphoma
Radiotherapy plus chemotherapy drive risk of pancreatic cancer in HL patientsAugust 13, 2014GastroenterologyLymphoma & Plasma Cell DisordersPatient & Survivor CareGastrointestinal Cancer
FDA approves idelalisib for three leukemia and lymphoma indicationsJuly 23, 2014Lymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, TransplantationFollicular Lymphoma
De-escalation of ABVD chemotherapy fails in early-stage, favorable Hodgkin’s lymphomaJuly 7, 2014Lymphoma & Plasma Cell Disorders
De-escalation of ABVD chemotherapy fails in early-stage, favorable Hodgkin’s lymphomaJuly 7, 2014Lymphoma & Plasma Cell Disorders
